- World Health Organization. Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020.
- Sakurai A, Sasaki T, Kato S, Hayashi M, Tsuzuki SI, Ishihara T, Iwata M, Morise Z, Doi Y. Natural History of Asymptomatic SARS-CoV-2 Infection. New England Journal of Medicine. 2020.
- Bajema KL, Oster AM, McGovern OL, Lindstrom S, Stenger MR, Anderson TC, Isenhour C, Clarke KR, Evans ME, Chu VT, Biggs HM. Persons evaluated for 2019 novel coronavirus—United States, January 2020. Morbidity and Mortality Weekly Report. 2020;69:166.
- Patel A, Jernigan DB. Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak—United States, December 31, 2019–February 4, 2020. Morbidity and Mortality Weekly Report. 2020;69:140.
- Ji D, Zhang D, Xu J, Chen Z, Yang T, Zhao P, Chen G, Cheng G, Wang Y, Bi J, Tan L. Prediction for progression risk in patients with COVID-19 pneumonia: the CALL Score. Clinical Infectious Diseases. 2020 .
- Elza Rechtman1, Paul Curtin1, Esmeralda Navarro1, Sharon Nirenberg2 & Megan K. Horton vital signs assessed in initial clinicalencounters predict COVID 19 mortality in an NYC hospitalsystem. Scientifc Reports | 2020; 10:21545.
- Ai-Ping Yang, Jian-ping Liu, Wen-qiang Tao, Hui-ming Li. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. International Immunopharmacology 84 (2020) 106504.
- Zhang, P. Zou, H. Gao, M. Yang. Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study, Ther. Clin. Risk Manag. 2019
- N Zhu, D Zhang, W Wang. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med (2020) published online Jan 24.
- Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis 2020.
- Zhang G, Zhang J, Wang B, Zhu X, Wang Q, Qiu S. Analysis of clinical characteristics and laboratory findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a retrospective analysis. Respir Res. 2020; 21:74.
- Liu Z., Long W., Tu M., Chen S., Huang Y., Wang S., Zhou W., Chen D., Zhou L., Wang M., Wu M., Huang Q., Xu H., Zeng W., Guo L. Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19. J. Infect. 2020.
- Lagunas-Rangel FA. Lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis. J Med Virol. 2020.
- Matsumoto H., Kasai T., Sato A., Ishiwata S., Yatsu S., Shitara J. Association between C-reactive protein levels at hospital admission and long-term mortality in patients with acute decompensated heart failure. Heart Vessels. 2019;34:1961–68. doi: 10.1007/s00380-019-01435-9
- Hai-Han Yu1, Chuan Qin1, Man Chen, Wei Wang, Dai-Shi Tian, D-dimer level is associated with the severity of COVID-19. Thrombosis Research195,2020:219–25.
|